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Saudi ArabiaAbstract Patient education is one of the main factors of patient therapeutic plan and without it,
the patient may not beneﬁt from his/her medications. Several studies showed the effectiveness of
educating patients about their disease(s) and their medication(s) which ultimately enhance their
quality of life especially in chronic diseases such as diabetes mellitus and hypertension. Concept
of patient education is well known and understood in the Western countries while in the
Kingdom of Saudi Arabia it is not well established despite some efforts made by few big hospitals.
In Saudi Arabia, different stakeholders such as hospitals, pharmaceutical companies, healthcare
professionals, health societies and association and governmental agencies do not do their job as
patient education. Aim of this paper was to throw some light about the current situation in
Saudi Arabia.
ª 2015 The Author. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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and medicine is the knowledge and the awareness of the
patient of their illness and medications. This is known as ‘‘gen-
eral health knowledge’’ as this term is the most used term in
the scientiﬁcally and medically developed and advanced coun-
tries all over the world. Moreover, the patient should be part
of his or her medical plan (Weed, 1997). Nonetheless, unfortu-
nately, this concept was not fully focused on or largely applied
in the Kingdom of Saudi Arabia except for a few limited appli-
cations established only by the famous and large hospitals in
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(Al-Ghamdi et al., 2012; Alkatheri and Albekairy, 2013).
Patient awareness or knowledge is considered the ﬁrst pillar
of the treatment process. Not only does this include his or
her understanding of the drugs, but also includes other aspects
of care such as a full understanding of the disease(s) the patient
suffers from, and disease prevention precautions (Stromberg,
2005).
The terms awareness and knowledge in health are not dif-
ferent from other forms of life knowledge including business
and family affairs; however, health awareness and knowledge
should be the priority as they affect all activities in the patient’s
life. One example of the patient’s awareness is his or her under-
standing of the important role of physical activities and exer-
cise (such as walking, jogging or swimming) in the
prevention of several chronic illnesses including preventing
obesity, which is well-known in its relationship of triggering
such additional chronic illnesses including diabetes and cardio-
vascular diseases (Bassuk and Manson, 2005; Stromberg, 2005;
Vanhees et al., 2012).
One of the pillars of health awareness is medicinal educa-
tion so that the patient is fully knowledgeable about all his
or her dispensed medications and also the necessary instruc-
tions for the proper use of such medications (Micheli et al.,
2007). In countries such as Canada, one can ﬁnd that the
majority of the population has general knowledge about the
medications and they seek further information about the med-
ication they use for conditions they have; thus, deﬁning what
we mean by the term medicinal education or knowledge
(Guenette and Moisan, 2011). For example, most of the cold,
cough and allergy medications are sold over the counter in
pharmacies and other shopping centers so patients can go
and buy what they need in case they have cold or allergy or
other mild disease. Further, with the new technology and
new methods that are used by pharmaceutical companies such
as direct to consumer advertisement (DTC), the patient would
know or guess the diagnosis of his/her illness and know the
appropriate medications he or she would need for his or her
condition (Wilkes et al., 2000). Around 75% of the patients,
they received the medications that they tell the physician about
them for their condition (APA, 1997). One can ﬁnd the
patients, and people in general, in the Western countries are
keen to know about the medication they use and that in gen-
eral, they discuss the information they obtain with their physi-
cians (Wilkes et al., 2000). In addition to the eagerness of the
patients to gather information from different resources, inter-
net access has helped tremendously to provide necessary infor-
mation about diseases, medications for treatment, and
alternatives forms of care strategies (Ilic, 2010). Studies have
shown that patient education regarding medications leads to
the commitment of the patient to drug therapy manifested
by proper use of the drugs which will eventually lead to full
beneﬁt from medications and thus, curing the patients as well
as maintaining good health to perform daily life activities
(Abbott, 1998; Shah and Abu-Amara, 2013).
This does not mean that there are differences in the level of
general education between the patients of the Western coun-
tries and those of Saudi Arabia. However, the problem lies
with health care professionals (e.g., physicians, pharmacists,
and nurses) as they do not allocate enough time to discuss
the medications they prescribe with their patients; additionally,
they even do not provide detailed information about thediseases which the patents suffer from. In general, most of
the patients seek extensive information about their diseases
and the prescribed medications, as such, it is crucial that health
care professionals become proactive and allocate enough time
to discuss medications, the expected therapeutic outcomes and
the side effects with every patient. In addition, hospitals should
contain specialized centers where health care professionals,
especially pharmacists, can provide patient counseling and
answer patients’ inquires.
The information that general type of patients need is very
important to know and be educated about them. However,
patients with serious and severe disease need for more detailed
education because it is crucial for those patients’ life. For
instant, kidney disease, organ transplants, cancer, diabetic
depressed and cardiovascular patients are in need of speciﬁc
counseling and education about their disease and how to use
their medications; this education process should be frequent
(Clowers-Webb et al., 2006; Ellis et al., 2004; Johnston et al.,
1999; Robinson et al., 1997; Wilson et al., 2012). In the case
of patients with a liver or renal transplant, the healthcare pro-
fessionals need to spend more time discussing the importance
of taking medications on time, not missing the dose of
immunosuppressant, their life styles and other habits
(Chisholm et al., 2001).
We should not ignore the important role as patient educa-
tion that should be done by higher government agencies such
that is the Saudi Food and Drug Authority (SFDA) and the
Ministry of Health in medically educating patients, as they
always should make efforts in this prospective. We hope they
start the efforts and increase such efforts with more and more
campaigns so that more and more patients are being reached
and educated.
It is important that health associations and societies should
activate and increase their role and efforts in educating
patients in general health and speciﬁcally medicinal education.
Also, the role of community pharmacies in educating patients
is very important as a large percentage of the patients go
directly to the pharmacies to obtain their medications. Thus,
the active role of pharmacies would be effective in educating
patients about medications. One of the main issues that
Saudi patients are not getting the beneﬁt from, in respect to
patient education, is the role of pharmaceutical companies to
conduct educational campaigns for the public. Most of the
big pharmaceutical companies have interests in Saudi markets;
there are over 15 local pharmaceutical companies, and these
pharmaceutical companies do not do a good job as a role
and mission toward educating the Saudi population about
either diseases or even their own medicinal products. On the
other hand, these companies are very active in promoting med-
ications to the healthcare professionals (HCPs) especially
physicians. In addition, these companies would do campaigns,
lectures, symposiums and sometimes send HCPs outside the
country to attend meetings and conferences related to their
medicinal products. The cost of the aforementioned activities
conducted by pharmaceutical companies for HCPs would cost
way more than the cost of campaigns for the public and the
patients speciﬁcally. Therefore, companies should play a major
role here.
In the United States, there is a type of activity that usually
shared by pharmaceutical companies and media through their
different ways, which is the direct to consumer (DTC) adver-
tisement to advertise their medications. This activity could be
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are against DTC advertisement because it might not give the
full information about the drug especially the adverse drug
reactions (Wilkes et al., 2000). In Saudi Arabia, this method
is not utilized well for the purpose of patient education, as
the SFDA do not control it well despite their efforts.
The media play a signiﬁcant role in this prospective as they
could provide awareness and educational campaigns to the
public via radio and visual media. As media reach a large
percentage of the population, this would make it suitable for
delivering those messages. Further, Saudi hospitals, clinics or
societies in Saudi Arabia publish few educational websites in
the Arabic language. However, there is some effort being made
by some big governments and private hospitals but there is not
enough campaign to raise awareness among patients regarding
the use of these websites and how to beneﬁt from them. On the
other hand, several studies found many educational Web site
in the English language; these are considered a rich source
for the patients who used them for educational purposes
(Diaz et al., 2002; Eysenbach et al., 2002; Miller et al., 2013).
Even though someone would consider medicinal knowledge
a minor topic, the actual fact is that medicinal knowledge is the
ﬁrst and most important step in treating the patients and it
would avoid and prevent the occurrence of multiple health
problems that would have been caused by limited education
of the patients. Therefore, all stakeholders in Saudi Arabia
(i.e., hospitals, healthcare professionals, health professional
societies, health government agencies, media and pharmaceuti-
cal companies) should have a role in educating and enhancing
patient’s knowledge with respect to their disease and med-
ications and each of the stakeholders has a unique role based
on their experiences and ﬁeld.
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